When to consider inherited marrow failure syndromes in adults

2.

Bluteau

O

,

Sebert

M

,

Leblanc

T

, et al.

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

.

Blood

.

2018

;

131

(

7

):

717

-

732

.

doi:10.1182/blood-2017-09-806489

.

3.

Young

NS

.

Aplastic anemia

.

N Engl J Med

.

2018

;

379

(

17

):

1643

-

1656

.

doi:10.1056/NEJMra1413485

.

4.

Groarke

EM

,

Young

NS

,

Calvo

KR

.

Distinguishing constitutional from acquired bone marrow failure in the hematology clinic

.

Best Pract Res Clin Haematol

.

2021

;

34

(

2

):

101275

.

doi:10.1016/j.beha.2021.101275

.

5.

Gutierrez-Rodrigues

F

,

Santana-Lemos

BA

,

Scheucher

PS

,

Alves-Paiva

RM

,

Calado

RT

.

Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans

.

PLoS One

.

2014

;

9

(

11

):

e113747

.

doi:10.1371/journal.pone.0113747

.

6.

Gutierrez-Rodrigues

F

,

Sahoo

SS

,

Wlodarski

MW

,

Young

NS

.

Somatic mosaicism in inherited bone marrow failure syndromes

.

Best Pract Res Clin Haematol

.

2021

;

34

(

2

):

101279

.

doi:10.1016/j.beha.2021.101279

.

7.

Betensky

M

,

Babushok

D

,

Roth

JJ

, et al.

Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia

.

Cancer Genet

.

2016

;

209

(

1-2

):

1

-

10

.

doi:10.13039/100000050

.

8.

Shah

YB

,

Priore

SF

,

Li

Y

, et al.

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis

.

Blood Adv

.

2021

;

5

(

16

):

3216

-

3226

.

doi:10.1182/bloodadvances.2021004201

.

9.

Groarke

EM

,

Patel

BA

,

Shalhoub

R

, et al.

Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia

.

Leukemia

.

2022

;

36

(

9

):

2328

-

2337

.

doi:10.1038/s41375-022-01636-8

.

10.

Yoshizato

T

,

Dumitriu

B

,

Hosokawa

K

, et al.

Somatic mutations and clonal hematopoiesis in aplastic anemia

.

N Engl J Med

.

2015

;

373

(

1

):

35

-

47

.

doi:10.1056/NEJMoa1414799

.

11.

Ogawa

S.

Genetics of MDS

.

Blood

.

2019

;

133

(

10

):

1049

-

1059

.

doi:10.1182/blood-2018-10-844621

.

12.

Muramatsu

H

,

Okuno

Y

,

Yoshida

K

, et al.

Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes

.

Genet Med

.

2017

;

19

(

7

):

796

-

802

.

doi:10.1038/gim.2016.197

.

13.

Ghemlas

I

,

Li

H

,

Zlateska

B

, et al.

Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes

.

J Med Genet

.

2015

;

52

(

9

):

575

-

584

.

doi:10.1136/jmedgenet-2015-103270

.

14.

McReynolds

LJ

,

Rafati

M

,

Wang

Y

, et al.

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes

.

Blood

.

2022

;

140

(

8

):

909

-

921

.

doi:10.1182/blood.2022016508

.

15.

Feurstein

S

,

Trottier

AM

,

Estrada-Merly

N

, et al.

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

.

Blood

.

2022

;

140

(

24

):

2533

-

2548

.

doi:10.1182/blood.2022015790

.

16.

Alter

BP

,

Giri

N

,

Savage

SA

,

Rosenberg

PS

.

Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up

.

Haematologica

.

2018

;

103

(

1

):

30

-

39

.

doi:10.3324/haematol.2017.178111

.

17.

Gutierrez-Rodrigues

F

,

Munger

E

,

Ma

X

, et al.

Differential diagnosis of bone marrow failure syndromes guided by machine learning

.

Blood

.

2022

.

doi:10.1182/blood.2022017518

.

18.

Kim

H-Y

,

Kim

H-J

,

Kim

S-H

.

Genetics and genomics of bone marrow failure syndrome

.

Blood Res

.

2022

;

57

(

S1

):

s86

-

S92

.

doi:10.5045/br.2022.2022056

.

19.

Niewisch

MR

,

Giri

N

,

McReynolds

LJ

, et al.

Disease progression and clinical outcomes in telomere biology disorders

.

Blood

.

2022

;

139

(

12

):

1807

-

1819

.

doi:10.1182/blood.2021013523

.

20.

Boria

I

,

Garelli

E

,

Gazda

HT

, et al.

The ribosomal basis of diamond-blackfan anemia: mutation and database update

.

Hum Mutat

.

2010

;

31

(

12

):

1269

-

1279

.

doi:10.1002/humu.21383

.

21.

Walne

AJ

,

Vulliamy

T

,

Beswick

R

,

Kirwan

M

,

Dokal

I.

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes

.

Blood

.

2008

;

112

(

9

):

3594

-

3600

.

doi:10.1182/blood-2008-05-153445

.

22.

Calvo

KR

,

Hickstein

DD

.

The spectrum of GATA2 deficiency syndrome

.

Blood

.

2023

;

141

(

13

):

1524

-

1532

.

doi:10.1182/blood.2022017764

.

23.

Ganapathi

KA

,

Townsley

DM

,

Hsu

AP

, et al.

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

.

Blood

.

2015

;

125

(

1

):

56

-

70

.

doi:10.1182/blood-2014-06-580340

.

24.

Homan

CC

,

Scott

HS

,

Brown

AL

.

Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26

.

Blood

.

2023

;

141

(

13

):

1533

-

1543

.

doi:10.1182/blood.2022017735

.

25.

Germeshausen

M

,

Ancliff

P

,

Estrada

J

, et al.

MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia

.

Blood Adv

.

2018

;

2

(

6

):

586

-

596

.

doi:10.1182/bloodadvances.2018016501

.

26.

Tangye

SG

,

Al-Herz

W

,

Bousfiha

A

, et al.

Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee

.

J Clin Immunol

.

2022

;

42

(

7

):

1473

-

1507

.

doi:10.1007/s10875-022-01289-3

.

27.

Sebert

M

,

Gachet

S

,

Leblanc

T

, et al.

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia

.

Cell Stem Cell

.

2023

;

30

(

2

):

153

-

170.e9170e9

.

doi:10.1016/j.stem.2023.01.006

.

28.

Sahoo

SS

,

Pastor

VB

,

Goodings

C

, et al;

European Working Group of MDS in Children (EWOG-MDS)

.

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

.

Nat Med

.

2021

;

27

(

10

):

1806

-

1817

.

doi:10.1038/s41591-021-01511-6

.

29.

Groarke

EM

,

Gutierrez-Rodrigues

F

,

Ma

X

, et al.

U2AF1 and other splicing factor gene mutations in telomere biology disorders are associated with hematologic neoplasia and worse overall survival

.

Blood

.

2021

;

138

:

862

.

doi:10.1182/blood-2021-146946

.

30.

Kennedy

AL

,

Myers

KC

,

Bowman

J

, et al.

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman- Diamond syndrome

.

Nat Commun

.

2021

;

12

(

1

):

1334

.

doi:10.1038/s41467-021-21588-4

.

31.

Kraft

IL

,

Godley

LA

.

Identifying potential germline variants from sequencing hematopoietic malignancies

.

Blood

.

2020

;

136

(

22

):

2498

-

2506

.

doi:10.1182/blood.2020006910

.

32.

Feurstein

S

,

Hahn

CN

,

Mehta

N

,

Godley

LA

.

A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias

.

Genet Med

.

2022

;

24

(

4

):

931

-

954

.

doi:10.13039/501100018936

.

33.

Armes

H

,

Rio-Machin

A

,

Krizsán

S

, et al.

Acquired somatic variants in inherited myeloid malignancies

.

Leukemia

.

2022

;

36

(

5

):

1377

-

1381

.

doi:10.13039/100010661

.

34.

Li

P

,

Brown

S

,

Williams

M

, et al.

The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms

.

Blood

.

2022

;

140

(

7

):

716

-

755

.

doi:10.1182/blood.2021015135

.

35.

Bonfim

C.

Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes

.

Hematology Am Soc Hematol Educ Program

.

2020

;

2020

(

1

):

107

-

114

.

doi:10.1182/hematology.2020000095

.

36.

Fioredda

F

,

Iacobelli

S

,

Korthof

ET

, et al.

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita

.

Br J Haematol

.

2018

;

183

(

1

):

110

-

118

.

doi:10.1111/bjh.15495

.

37.

Dufour

C

,

Pierri

F.

Modern management of Fanconi anemia

.

Hematology

.

2022

;

2022

(

1

):

649

-

657

.

doi:10.1182/hematology.2022000393

.

38.

Nelson

AS

,

Myers

KC

.

Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome

.

Hematol/Oncol Clin N Am

.

2018

;

32

(

4

):

687

-

700

.

doi:10.1016/j.hoc.2018.04.006

.

39.

Da Costa

L

,

Leblanc

T

,

Mohandas

N.

Diamond-Blackfan anemia

.

Blood

.

2020

;

136

(

11

):

1262

-

1273

.

doi:10.1182/blood.2019000947

.

40.

Shabanova

I

,

Cohen

E

,

Cada

M

,

Vincent

A

,

Cohn

RD

,

Dror

Y.

ERCC6L2- associated inherited bone marrow failure syndrome

.

Mol Genet Genomic Med

.

2018

;

6

(

3

):

463

-

468

.

doi:10.1002/mgg3.388

.

41.

Zhou

Q

,

Yang

D

,

Ombrello

AK

, et al.

Early-Onset stroke and vasculopathy associated with mutations in ADA2

.

N Engl J Med

.

2014

;

370

(

10

):

911

-

920

.

doi:10.1056/NEJMoa1307361

.

42.

Auerbach

AD

.

Diagnosis of Fanconi anemia by diepoxybutane analysis

.

Curr Protoc Hum Genet

.

2015

;

85

:8.7.1-8.717.

doi:10.1002/0471142905.hg0807s85

.

43.

Blanche

PA

,

Philip

SR

,

Neelam

G

,

Gabriela

MB

,

Peter

ML

,

Sharon

AS

.

Telomere length is associated with disease severity and declines with age in dyskeratosis congenita

.

Haematologica

.

2012

;

97

(

3

):

353

-

359

.

doi:10.3324/haematol.2011.055269

.